2m 2m 2m 2m 2m 2m 2m
VALNEVA SP ADS (VALN)
NASDAQ
$5.39+$0.04 (+0.75%)
Price as of Jun 23, 2026 4:10 PM EDT- $507.3MMarket Cap
- -4.29%1-Year Change
- BiotechnologyIndustry
VALNEVA SP ADS (VALN)
$5.39+$0.04 (+0.75%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 174.7M +3.00% | 169.6M +10.32% | 153.7M -57.46% | 361.3M +3.80% | |
Cost of Revenue | 107.1M +8.73% | 98.5M -2.32% | 100.9M -68.91% | 324.4M +72.65% | |
Gross Profit | 67.5M -4.96% | 71.0M +34.45% | 52.8M +43.34% | 36.9M -76.99% | |
Sales and Marketing Expense | 9.0M -46.13% | 16.8M +25.60% | 13.4M +81.96% | 7.3M -84.58% | |
Research and Development Expense | -85.3M +15.05% | -74.1M +23.79% | -59.9M -42.92% | -104.9M -39.45% | |
Depreciation and Amortization Expense | 21.8M +11.05% | 19.6M +11.39% | 17.6M -16.41% | 21.0M N/A | |
Total Operating Expenses | 37.3M -12.70% | 42.8M -10.56% | 47.8M +40.28% | 34.1M -28.43% | |
Operating Profit | -82.1M -715.60% | 13.3M +116.24% | -82.1M -27.64% | -113.4M +84.79% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | -115.2M +840.57% | -12.2M -87.93% | -101.4M -29.21% | -143.3M +95.14% | |
Income Taxes | 1.1M +41.00% | 761,000 -72.82% | 2.8M +282.29% | -1.5M -144.57% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -115.2M +840.57% | -12.2M -87.93% | -101.4M -29.21% | -143.3M +95.14% | |
Net Income from Continuing Operations Applicable to Common | -115.2M +840.57% | -12.2M -87.93% | -101.4M -29.21% | -143.3M +95.14% | |
Basic EPS and Net Income | -0.68 +750.00% | -0.08 -89.04% | -0.73 -41.13% | -1.24 +65.33% | |
Diluted EPS and Net Income | -0.68 +750.00% | -0.08 -89.04% | -0.73 -41.13% | -1.24 +65.33% | |
Basic Weighted Average Shares | 168.2M +15.42% | 145.7M +5.11% | 138.6M +20.05% | 115.5M +18.29% | |
Diluted Weighted Average Shares | 168.2M +15.42% | 145.7M +5.11% | 138.6M +20.05% | 115.5M +18.29% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 109.7M -34.84% | 168.3M +33.46% | 126.1M -56.44% | 289.4M -16.52% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 109.7M -34.84% | 168.3M +33.46% | 126.1M -56.44% | 289.4M -16.52% | |
Total Current Assets | 222.5M -25.57% | 299.0M +13.77% | 262.8M -38.11% | 424.7M -27.51% | |
Accumulated Depreciation | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 119.5M -13.98% | 138.9M +1.97% | 136.2M +21.13% | 112.4M -10.44% | |
Total Long-Term Assets | 176.3M -12.30% | 201.0M +1.92% | 197.2M +0.28% | 196.7M -15.05% | |
Total Assets | 398.8M -20.24% | 500.0M +8.69% | 460.1M -25.96% | 621.3M -23.98% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 93.3M -18.54% | 114.6M -27.87% | 158.9M -42.73% | 277.4M -24.82% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 199.3M -2.38% | 204.2M +18.07% | 173.0M +39.30% | 124.2M -55.31% | |
Total Liabilities | 292.7M -8.19% | 318.8M -3.93% | 331.8M -17.37% | 401.5M -37.92% | |
Retained Earnings | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Stockholders Equity | 106.2M -41.43% | 181.3M +41.33% | 128.2M -41.65% | 219.8M +28.85% | |
Total Shares Outstanding | 173.4M +6.78% | 162.4M +17.01% | 138.8M +0.39% | 138.2M +31.52% | |
Cash Flow | |||||
Cash from Operating Activities | -52.9M -21.31% | -67.2M -66.85% | -202.7M -17.36% | -245.3M -419.04% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -1.7M -102.22% | 76.9M +473.65% | -20.6M -29.15% | -29.1M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -621,000 -102.02% | 30.7M -51.36% | 63.1M -70.68% | 215.1M N/A | |
Financials Ratio | |||||
Gross Margin | 38.66% -7.72% | 41.89% +21.87% | 34.37% +236.92% | 10.20% N/A | |
Operating Margin | -46.98% -697.70% | 7.86% +114.72% | -53.40% +70.08% | -31.40% N/A | |
Return on Assets | -25.63% +904.64% | -2.55% -86.40% | -18.76% -5.82% | -19.92% N/A | |
Return on Equity | -80.16% +912.82% | -7.91% -86.42% | -58.29% -20.60% | -73.41% N/A | |
Revenue Growth | 3.00% -70.98% | 10.32% +117.96% | -57.46% -1,613.15% | 3.80% N/A | |
Current Ratio | 2.38 -8.63% | 2.61 +57.74% | 1.65 +8.07% | 1.53 N/A | |
Cash Ratio | 1.17 -20.01% | 1.47 +85.06% | 0.79 -23.94% | 1.04 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow